Drugs Approved for Skin Cancer - National Cancer Institute

Drugs Approved for Skin Cancer - National Cancer Institute

Drugs Approved for Skin Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for skin cancer, including drugs for basal cell carcinoma, melanoma, and merkel cell carcinoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in skin cancer that are not listed here.

ON THIS PAGE

• Drugs Approved for Basal Cell Carcinoma
• Drugs Approved for Cutaneous Squamous Cell Carcinoma
• Drugs Approved for Melanoma
• Drugs Approved for Merkel Cell Carcinoma

Drugs Approved for Basal Cell Carcinoma

• Aldara (Imiquimod)
• Efudex (Fluorouracil--Topical)
• Erivedge (Vismodegib)
• 5-FU (Fluorouracil--Topical)
• Fluorouracil--Topical
• Imiquimod
• Odomzo (Sonidegib)
• Sonidegib
• Vismodegib

Drugs Approved for Cutaneous Squamous Cell Carcinoma

• Cemiplimab-rwlc
• Libtayo (Cemiplimab-rwlc)

Drugs Approved for Melanoma

• Aldesleukin
• Cobimetinib
• Cotellic (Cobimetinib)
• Dabrafenib
• Dacarbazine
• DTIC-Dome (Dacarbazine)
• IL-2 (Aldesleukin)
• Imlygic (Talimogene Laherparepvec)
• Interleukin-2 (Aldesleukin)
• Intron A (Recombinant Interferon Alfa-2b)
• Ipilimumab
• Keytruda (Pembrolizumab)
• Mekinist (Trametinib)
• Nivolumab
• Opdivo (Nivolumab)
• Peginterferon Alfa-2b
• Pembrolizumab
• Proleukin (Aldesleukin)
• Recombinant Interferon Alfa-2b
• Sylatron (Peginterferon Alfa-2b)
• Tafinlar (Dabrafenib)
• Talimogene Laherparepvec
• Trametinib
• Vemurafenib
• Yervoy (Ipilimumab)
• Zelboraf (Vemurafenib)

Drugs Approved for Merkel Cell Carcinoma

• Avelumab
• Bavencio (Avelumab)
• Keytruda (Pembrolizumab)
• Pembrolizumab

Related Resources

• Skin Cancer (Including Melanoma)—Patient Version
• Chemotherapy and You: Support for People With Cancer

• Updated: October 17, 2018